Michael Grusch

6.5k total citations
161 papers, 4.7k citations indexed

About

Michael Grusch is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Michael Grusch has authored 161 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Molecular Biology, 51 papers in Oncology and 34 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Michael Grusch's work include Fibroblast Growth Factor Research (27 papers), Occupational and environmental lung diseases (22 papers) and Kruppel-like factors research (17 papers). Michael Grusch is often cited by papers focused on Fibroblast Growth Factor Research (27 papers), Occupational and environmental lung diseases (22 papers) and Kruppel-like factors research (17 papers). Michael Grusch collaborates with scholars based in Austria, Hungary and Germany. Michael Grusch's co-authors include Walter Berger, Georg Krupitza, Brigitte Marian, Bettina Grasl‐Kraupp, Thomas Szekeres, M. Micksche, Klaus Holzmann, Monika Fritzer‐Szekeres, Balázs Hegedűs and Leonilla Elbling and has published in prestigious journals such as The EMBO Journal, PLoS ONE and Hepatology.

In The Last Decade

Michael Grusch

157 papers receiving 4.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Michael Grusch Austria	41	2.9k	1.1k	783	646	340	161	4.7k
Juliane M. Jürgensmeier United States	30	3.7k 1.3×	1.3k 1.2×	738 0.9×	533 0.8×	493 1.4×	69	5.4k
Dhyan Chandra United States	38	3.1k 1.1×	1.2k 1.1×	928 1.2×	540 0.8×	348 1.0×	71	4.8k
Byong Chul Yoo South Korea	37	2.7k 0.9×	755 0.7×	786 1.0×	341 0.5×	191 0.6×	137	4.5k
Alexander T.H. Wu Taiwan	40	2.6k 0.9×	1.1k 1.0×	1.1k 1.4×	684 1.1×	292 0.9×	170	5.1k
Mei Wang China	34	2.4k 0.8×	617 0.6×	718 0.9×	331 0.5×	279 0.8×	146	4.0k
Ying Yan China	34	2.6k 0.9×	1.2k 1.1×	521 0.7×	382 0.6×	402 1.2×	170	4.1k
Chris van Bree Netherlands	18	2.3k 0.8×	1.2k 1.1×	793 1.0×	622 1.0×	175 0.5×	47	4.4k
Christopher L. Morton United States	45	3.2k 1.1×	1.5k 1.4×	663 0.8×	915 1.4×	229 0.7×	128	5.6k
Georg Krupitza Austria	33	2.7k 1.0×	1.4k 1.3×	853 1.1×	309 0.5×	188 0.6×	134	5.0k

Countries citing papers authored by Michael Grusch

Since Specialization

Citations

This map shows the geographic impact of Michael Grusch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Grusch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Grusch more than expected).

Fields of papers citing papers by Michael Grusch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Grusch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Grusch. The network helps show where Michael Grusch may publish in the future.

Co-authorship network of co-authors of Michael Grusch

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Grusch. A scholar is included among the top collaborators of Michael Grusch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Grusch. Michael Grusch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schelch, Karin, Dominik Kirchhofer, Gerald Timelthaler, et al.. (2025). Inhibition of YB-1 phosphorylation enhances cisplatin activity and disrupts cell division in pleural mesothelioma. British Journal of Cancer. 133(9). 1391–1400.

Rodríguez, Javier, Alex von Kriegsheim, Michael Grusch, et al.. (2024). ERK 1/2 mitogen‐activated protein kinase dimerization is essential for the regulation of cell motility. Molecular Oncology. 19(2). 452–473. 5 indexed citations

Schelch, Karin, Thomas Mohr, Thomas Klikovits, et al.. (2023). Circulating FGF18 is decreased in pleural mesothelioma but not correlated with disease prognosis. Thoracic Cancer. 14(22). 2177–2186. 1 indexed citations

Slany, Astrid, Christine Pirker, Johanna C. Mader, et al.. (2023). Mesothelioma-associated fibroblasts enhance proliferation and migration of pleural mesothelioma cells via c-Met/PI3K and WNT signaling but do not protect against cisplatin. Journal of Experimental & Clinical Cancer Research. 42(1). 27–27. 13 indexed citations

Slany, Astrid, Christine Pirker, Johanna C. Mader, et al.. (2023). Primary and hTERT-Transduced Mesothelioma-Associated Fibroblasts but Not Primary or hTERT-Transduced Mesothelial Cells Stimulate Growth of Human Mesothelioma Cells. Cells. 12(15). 2006–2006. 2 indexed citations

Boettiger, Kristiina, Ildikó Kovács, Christian Lang, et al.. (2023). Entinostat Enhances the Efficacy of Chemotherapy in Small Cell Lung Cancer Through S-phase Arrest and Decreased Base Excision Repair. Clinical Cancer Research. 29(22). 4644–4659. 15 indexed citations

Schenkeveld, Walter D. C., Maura Tomatis, Karin Schelch, et al.. (2022). The Potential Contribution of Hexavalent Chromium to the Carcinogenicity of Chrysotile Asbestos. Chemical Research in Toxicology. 35(12). 2335–2347. 4 indexed citations

Schelch, Karin, Thomas Mohr, Rupert L. Mayer, et al.. (2021). EGF Induces Migration Independent of EMT or Invasion in A549 Lung Adenocarcinoma Cells. Frontiers in Cell and Developmental Biology. 9. 634371–634371. 23 indexed citations

Holzmann, Klaus, Brigitte Marian, Thomas Mohr, et al.. (2020). Interaction of FGF9 with FGFR3‐IIIb/IIIc, a putative driver of growth and aggressive behaviour of hepatocellular carcinoma. Liver International. 40(9). 2279–2290. 14 indexed citations

10.

Tubin, S., Seema Gupta, Michael Grusch, et al.. (2020). Shifting the Immune-Suppressive to Predominant Immune-Stimulatory Radiation Effects by SBRT-PArtial Tumor Irradiation Targeting HYpoxic Segment (SBRT-PATHY). Cancers. 13(1). 50–50. 38 indexed citations

11.

László, Viktória, Ildikó Kovács, Mir Alireza Hoda, et al.. (2018). Nintedanib Is Active in Malignant Pleural Mesothelioma Cell Models and Inhibits Angiogenesis and Tumor Growth In Vivo. Clinical Cancer Research. 24(15). 3729–3740. 25 indexed citations

12.

Klikovits, Thomas, Paul Stockhammer, Viktória László, et al.. (2017). Circulating complement component 4d (C4d) correlates with tumor volume, chemotherapeutic response and survival in patients with malignant pleural mesothelioma. Scientific Reports. 7(1). 16456–16456. 20 indexed citations

13.

Hoda, Mir Alireza, Christine Pirker, Karin Schelch, et al.. (2016). Trabectedin Is Active against Malignant Pleural Mesothelioma Cell and Xenograft Models and Synergizes with Chemotherapy and Bcl-2 Inhibition In Vitro. Molecular Cancer Therapeutics. 15(10). 2357–2369. 17 indexed citations

14.

Grusch, Michael, Karin Schelch, Eva Reichhart, et al.. (2014). Spatio‐temporally precise activation of engineered receptor tyrosine kinases by light. The EMBO Journal. 33(15). 1713–1726. 199 indexed citations

15.

Heinzle, Christine, Andrea Gsur, Christine Gauglhofer, et al.. (2012). Differential Effects of Polymorphic Alleles of FGF Receptor 4 on Colon Cancer Growth and Metastasis. Cancer Research. 72(22). 5767–5777. 41 indexed citations

16.

Losert, Annemarie, Daniela Lötsch, Andreas Lackner, et al.. (2012). The major vault protein mediates resistance to epidermal growth factor receptor inhibition in human hepatoma cells. Cancer Letters. 319(2). 164–172. 29 indexed citations

17.

Fischer, Hendrik, Ninon Taylor, Michael Grusch, et al.. (2008). Fibroblast growth factor receptor-mediated signals contribute to the malignant phenotype of non-small cell lung cancer cells: therapeutic implications and synergism with epidermal growth factor receptor inhibition. Molecular Cancer Therapeutics. 7(10). 3408–3419. 86 indexed citations

18.

Lackner, Andreas, Herwig Koppensteiner, Irene Herbacek, et al.. (2008). A bicistronic baculovirus vector for transient and stable protein expression in mammalian cells. Analytical Biochemistry. 380(1). 146–148. 5 indexed citations

19.

Saiko, Philipp, Monika Fritzer‐Szekeres, Zsuzsanna Bagó-Horváth, et al.. (2006). Biochemical effects of Piceatannol in human HL-60 promyelocytic leukemia cells - synergism with Ara-C. Cancer Research. 66. 1113–1113. 16 indexed citations

20.

Grusch, Michael, Doris Polgar, C. Leisser, et al.. (2002). Maintenance of ATP favours apoptosis over necrosis triggered by benzamide riboside. Cell Death and Differentiation. 9(2). 169–178. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact